Collaborative Arrangements
National
Cochlear Limited is the world leader in the field of cochlear implants
for deaf adults and children. CRC HEAR research in collaboration with
Cochlear Limited focuses on improving technology and clinical processes.
CRC HEAR’s facilities for biological safety studies are critical
to Cochlear Ltd's ability to develop safe implantable prosthetics for
long-term use that incorporate continuous improvements. The University
of Wollongong’s Intelligent Polymer Research Institute and Griffith
University through its involvement in the CRC for Microtechnology support
our biomedical engineering studies. This allows CRC HEAR to address
the complex problems in developing new implantable hearing prostheses
incorporating new materials and capabilities as well as new electrode
fabrication methodologies, and increasing the skills base of cochlear
implant researchers in material science.
CRC HEAR’s research work with Cochlear Limited has led to the
development of new electrode designs that have received international
and Australian biomedical awards. The collaboration extends to the education
field with surgeons and clinicians around the world undertaking the
Cochlear Implant Training Workshop Program.
The National Acoustics Laboratories (the research arm of Australian
Hearing) have a well-deserved international reputation at the forefront
of research into fitting methodology for hearing aids. Coupled with
digital speech processing expertise from The Bionic Ear Institute and
The University of Melbourne, CRC HEAR research teams are addressing
issues that currently limit hearing aid use and developing solutions
that will improve perception in background noise.
The involvement of Australian Hearing together with the Cochlear Implant
Clinic at the Royal Victorian Eye and Ear Hospital in Melbourne, The
Sydney Cochlear Implant Clinic, and the Hear & Say Centre for Children
with Impaired Hearing and the Queensland Hearing Centre in Brisbane
help to ensure that innovations and clinical applications relevant to
hearing aids or cochlear implants have rapid access to one of the largest
networks of clinical centres in the world.
CRC HEAR links with our network of cochlear implant clinics and schools
also provide a significant patient pool for coordinated clinical trials
of specific innovations, assessment or fitting procedures or new approaches
to rehabilitation.
The involvement of schools for hearing-impaired children in Melbourne
and Sydney, and our links with The University of Melbourne’s Department
of Learning and Educational Development enable studies of the development
of speech and language and new habilitation procedures to maximise benefits
for all cochlear implant users.
The collaboration of the University of Sydney’s Department of
Surgery contributes to surgical studies for device innovation and to
the development of effective electrophysiological measures of patient
sensation levels, which will be valuable in enabling accurate programming
of the cochlear implant for infants.
CRC HEAR also addresses the question of cost utility and seeks to develop
cost-saving clinical procedures for cochlear implant and hearing aid
work.
CRC HEAR has benefited from the industry participation of hearing prosthetic
manufacturers, providing a mechanism for commercialisation of outputs,
as well as providing greater industry user involvement in and contributions
to research. Up to December 2003, Bernafon Australia provided research
staff and support for the Centre. Recently, Siemens, the world's largest
hearing aid company, has joined the CRC as its hearing industry partner.
Collaboration with the University of Melbourne’s School of Audiology
and the Audiological Society of Australia is a critical element of CRC
HEAR’s Education strategy, ensuring that the necessary skills
for using advanced hearing devices are incorporated into professional
continuing education programs developed by the CRC HEAR.
CRC HEAR provides a focus point for cochlear implant and hearing aid
research and collaboration both in Australia and internationally. CRC
HEAR conducts contract research with Australian and International partners,
helping to ensure the transfer of Australian technology to the international
marketplace.
International
- New York University Medical Centre
- University of Freiberg HNKO Klinic
- Massachusetts Institute of Technology
- University of Iowa
- University of Hong Kong
- Washington University School of Medicine
- Medizinische Hochschule Hannover (MHH)
- Kilmarnock Cochlear Implant Clinic
- Manchester Cochlear Implant Clinic
Internationally, CRC HEAR’s links with The New York University
Medical Centre, the University of Freiburg HNKO Klinic and MHH have
already greatly assisted the development of advanced electrode designs.
The involvement of these international groups allows for more rapid
accumulation of patients, and also adds to the international applicability
of research outcomes, which have been independently verified in a number
of research centres. An exciting new project with the University of
Hong Kong and Queen Elizabeth Hospital is addressing speech processing
for speakers of tonal languages.
New linkages are currently being established with the University of
Auckland and Hearing House in New Zealand.